Phase 1 and phase 2 results highlight promise of ADCs for hard-to-treat cancers

Three-year partnership to expand at-home health checks and vaccination access via NHS App

Linzagolix with add-back Therapy accepted for use within NHS Scotland

Blenrep combination offers improved survival for those ineligible for lenalidomide

Dutch biotech’s ORE-001 shows strong potential to prevent ileus after major surgery

New MHRA–FDA collaboration aims to boost patient access and AI safety

Positive safety and pharmacokinetic data lay foundation for phase 2 study in 2026

New survey reveals critical gaps in access to testing and timely care

Six new treatments aim to improve patient outcomes across key areas

UPSIDE study explores early transplant therapy for rare autoimmune disease